n = 358 Randomized Inoperable n = 358 Randomized Inoperable n = 179 TAVR n = 179 TAVR n = 179 Standard therapy n = 179 Standard therapy 124/124 patients 100% followed at 1 Yr 124/124 patients 100% followed at 1 Yr 85/85 patients 100% followed at 1 Yr 85/85 patients 100% followed at 1 Yr 99/102 patients* 97.1% followed at 2 Yr 99/102 patients* 97.1% followed at 2 Yr 56/56 patients 100% followed at 2 Yr 56/56 patients 100% followed at 2 Yr Study Flow Inoperable Cohort 9 5 withdrawals in the first year in Standard Rx arm5 withdrawals in the first year in Standard Rx arm *3 patients followed outside of protocol window in TAVR group*3 patients followed outside of protocol window in TAVR group No patients were lost to follow-upNo patients were lost to follow-up
{}